Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
sold half at 2.50 - playing with house money now !!!
$CLSN is screaming for the top, squeezing the shorts after announcing the termination of a share purchase agreement. https://cnafinance.com/clsn-stock-celsion-climbs-on-agreement-termination/
IN 1.25 OUT 2.25 NICE
Nothing as of yet. Volume poured in mid afternoon yesterday and continued after hours and again this AM. Lots if momentum on Twitter and stocktwits.
Any news? 4.6M shares pre-market and $2.22 !
in average at.82
I'M IN @1.25, WELL SEE
dunno but janey sure do likey
or it's a pump and dump
I forgot what I saw that brought me here, [SMART MONEY], but I did check their FINS...they lose a lot of money (comparatively speaking)...have no idea what's up with it... :)
Horrible performance, IMO. Keep an eye on her, there must be news coming or some force...
Link > https://www.sec.gov/Archives/edgar/data/749647/000149315220021447/form10q.htm
$CLSN wondering same didnt see any news or catalyst
asymphuckingtotic after hours
This one is flying under the radar . low float
clay who - hahaha
Hourly volume above average seems good for Longs or st traders
Ignoring clay trader lol
* * $CLSN Video Chart 07-23-2020 * *
Link to Video - click here to watch the technical chart video
Grabbed some 1.16's... Let's see what happens.. GL
Another great opportunity to buy $CLSN. Will go up very high from here. Had a conference call earlier with very promising discussions and forward outlook.
$CLSN aftermarket at $1.35! Looking for $1.4 open and possibly a $2+ close tomorrow.
Prefer to wait..if it turns and runs on good news I'll play it. GL
$CLSN
Don't get left behind. XD
Business call open to investors at 11 am tomorrow morning.
If it goes down that low. I'm averaged in at $1.18/$1.19. Hope you can get some shares for cheaper though.
I'll take some @ sub $1. GL
Unlike $BLU, which we both made money on last week, this company has more than one product in the works. Look up their GEN-1 treatment still undergoing clinical testing for multiple cancer types. This company isn't 'dead' because of the negative news the other day. Worth less? Sure. But way oversold at these levels. Again, more than one treatment. Other still holds promise. Google it and look it up on their site and read the information.
Either way, we'll see at this time tomorrow.
I'm not in because it's very likely they will not proceed forward. JMO
This will bounce by tomorrow - they will be having a call tomorrow to discuss the future of the company and put forth a plan forward. How can it not bounce? XD
* * $CLSN Video Chart 07-13-2020 * *
Link to Video - click here to watch the technical chart video
Today's PR was very likely a warning...once confirmed it will drop big again. I'll take .50-.60. RSI is still too high even with a 63% drop. JMO
Yikes! looks like 1.40+ early in the day WAS the bounce. Oh well, good thing I sold mine at 1.36 with stalled volume between 1-2 pm. Looks like those holding for a bigger bounce are selling now.
I hope you do well. My average PPS was way too high. I was late to the party. Not bitter... just glad I only have 100 shares in this one.
GLTY
Meh, momentum wasn't what I wanted. Volume was too low for a solid bounce play. Still made over a thousand bucks though. Time to move on..
$CLSN. I'm glad I piled up tens of thousands of shares earlier in the morning. Waiting for this to go back to $2 or at least close to $2 by end of day.
I makes tons of money each year on plays just like this one every year. Last week I made a ton of money on $BLU, which was very similar (poor results of testing, except in phase 2).
Will sell around $2 and then rinse and repeat with another biotech bounce play. Its always the same
$$$$$$$$$$$$$$$$$
I'm glad I only got 100 shares of this crap!
I told ya'll, around noon this will start taking off, and here we are. Expect large gains between 12-1 pm, 1-2pm, 2-3pm, etc. Once we crack 1.45, this will be headed to $2 by end of day, you'll see.
Regardless of fundamentals or forward outlook, this stock is going to be a bounce play. There's a ton of people accumulating on robin hood and ton of twitter posts mentioning as such and soon these posts will turn to pumping action (people who bought at these low prices and are trying to rally it further so they can sell out at $2). I would accumulate what you can afford between now and noon, and then sell at end of day or at open tomorrow.
Unfortunately, my suspicion of 42 month time mark
PFS cross over down come true to the worst outcome,
which means Thermodox arm patients has same or more
PFS patients after 42 month in the trial and no fat
OS KM tail to drive up efficacy, hence this look has
to stop the trial. I escaped second time, CLSN's
offering action and words in the last PR did give
me a hint.
$CLSN seems like a repeat of last week's $BLU. Looking for a good bounce play here. Will get out when this bounces back to $2.
1.25 and 1.26 Bid and Ask now pre-market on this garbage. Blood-effing bath and probably going to pennies. No confidence in anything these POS produce or release from this point forward.
DD22
POS leadership of this company KNEW the results of the second study of the phase 3 trials when they did that $10 Million dollar offerings last month. ABSOLUTE POFS MOVE AND I HOPE THEY GO BANKRUPT NOW AFTER F@cking all their shareholders. Criminals.
A BIG huge F@ck you CEO Michael Tardugno.
Douchebag is quoted as saying.
“This, of course, is inconclusive and difficult news for the medical community, HCC patients and our shareholders, and confirms the complexity and challenge of treating primary liver cancer,” he added. "The present development had never been anticipated by the Company or our advisors based on both the first pre-planned efficacy analysis and on tracking against the sub-group analysis of the Company’s earlier HEAT Study upon which the OPTIMA Study is based. We will conduct additional analyses of the unblinded data from the trial to better understand the results and to develop our plan going forward. As always, we wish to acknowledge and thank all the patients and investigators for their participation in the trial.”
The results sound pretty damn conclusive to me and the results had not been anticipated huh?? That’s why you sold $10 Million worth of shares last month ahead of these results. Lying POS.
I hope he dies of liver cancer.
DD22
News.
Blood bath to follow and shorts are gonna come to this in droves today.
https://www.globenewswire.com/news-release/2020/07/13/2061227/0/en/Celsion-Corporation-Receives-Recommendation-from-Independent-Data-Monitoring-Committee-to-Consider-Stopping-the-Phase-III-OPTIMA-Study.html
All IMO,
DD22
39% short volume on $CLSN. And we wonder why this gets TF beat out of it everyday. Criminal POS shorts.
https://stocktwits.com/shortvolumes/message/226455695
I hope the company destroys their azz with a massive positive news announcement soon.
All IMO,
DD22
Still speculative although good action today and hard to believe subset good first time bad niw
:)
Expecting some very good Phase III news soon.
Followers
|
255
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
16750
|
Created
|
08/02/09
|
Type
|
Free
|
Moderators |
Celsion is now funding branded oncology drug development through a fastest-path-to-commercialization strategy for ThermoDox®, its proprietary thermally sensitive liposomal encapsulation of doxorubicin. We are also identifying opportunities to expand our range of therapeutic indications through investments in our core technology platform.
To maximize global commercialization following approval, Celsion is developing distribution alliance opportunities for ThermoDox in key geographic markets. Once these are finalized we will seek to acquire additional platform technology and chemotherapeutic candidates to add to our development pipeline.
Celsion will continue to strengthen its prospects for the future through its research, license and commercialization agreements with leading institutions, among others; the National Institutes of Health, Duke University Medical Center, University of Hong Kong, Cleveland Clinic and the North Shore Long Island Jewish Health System.
CHART:
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |